Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.56 USD | -3.21% | -1.38% | +31.52% |
Mar. 15 | North American Morning Briefing : Inflation -2- | DJ |
Mar. 14 | Wells Fargo Upgrades NeuroPace to Overweight From Equalweight, Raises Price Target to $20 From $16 | MT |
Business Summary
Number of employees: 171
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Device
100.0
%
| 46 | 100.0 % | 65 | 100.0 % | +43.72% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 46 | 100.0 % | 65 | 100.0 % | +43.72% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joel Becker
CEO | Chief Executive Officer | 56 | 23-07-09 |
Rebecca Kuhn
FOU | Founder | 63 | 97-11-18 |
Frank Fischer
FOU | Founder | 82 | 97-11-30 |
Cairn Seale
CTO | Chief Tech/Sci/R&D Officer | 53 | 20-12-31 |
Martha Morrell
CTO | Chief Tech/Sci/R&D Officer | 66 | 97-11-18 |
Philip Taylor
IRC | Investor Relations Contact | - | - |
Stacey Ellul
LAW | General Counsel | - | 22-11-30 |
Irene Thomas
HRO | Human Resources Officer | 55 | 99-12-31 |
Dylan St. John
PRN | Corporate Officer/Principal | 46 | 12-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Andrade
BRD | Director/Board Member | 52 | 21-10-31 |
Joseph Lacob
BRD | Director/Board Member | 68 | 97-11-18 |
Frank Fischer
FOU | Founder | 82 | 97-11-30 |
Uri Geiger
BRD | Director/Board Member | 56 | 23-01-04 |
Renee Ryan
BRD | Director/Board Member | 55 | 20-07-31 |
Joel Becker
CEO | Chief Executive Officer | 56 | 23-07-09 |
Rakhi Kumar
BRD | Director/Board Member | 44 | 21-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 28,344,637 | 22,749,661 ( 80.26 %) | 0 | 80.26 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.52% | 402M | |
+8.78% | 219B | |
+8.24% | 187B | |
+11.16% | 134B | |
+26.12% | 101B | |
+0.30% | 62.27B | |
+16.21% | 52.82B | |
-1.63% | 47.49B | |
-1.11% | 40.79B | |
+12.16% | 39.35B |
- Stock Market
- Equities
- NPCE Stock
- Company NeuroPace, Inc.